Traumatic Brain Injury Clinical Trial
Official title:
"A Randomized, Controlled, Trial of Interactive Metronome Technology for Remediation of Cognitive Difficulties Following Blast-Related Traumatic Brain Injury"
The purpose of this research is to see whether adding a new therapy helps people with brain injury focus better and think more clearly. You are being asked to participate in this research study because you have had a brain injury. If you decide to volunteer, you will be in the study for about six months.As a participant, you will be randomly assigned to one of 2 treatment plans. Randomization is a process like flipping a coin and means you will have a chance of being assigned to either of the plans. One group will be given an experimental therapy using a metronome one hour a day, three times a week. A metronome is a device that produces a steady beat. You will need to keep time with the metronome doing several different movements. On each beat, you will be given information both through sound and on a computer screen about whether you were early or late and how far off beat you were. The tempo of the beat will be at 54 beats per minute, so you will need to process the feedback information very quickly to adjust your speed up or down to match the beat. The various movements include things like clapping hands, tapping toes, or alternating between different similar movements. It is hoped that the metronome will help subjects to concentrate better.
The design of this study will be a randomized, controlled trial of Interactive Metronome
(IM) treatment compared with treatment as usual in patients with moderate to mild Traumatic
Brain Injury (TBI) due to blast. The study will be conducted at the Evans Army Community
Hospital at Fort Carson, Colorado . Patients will be randomized to IM training, or to a
treatment as usual/wait-list control condition. Patients randomized to receive IM training
will complete 15 sessions consisting of approximately 2000 repetitions each. Patients
randomized to treatment as usual will be offered the opportunity to receive IM training
following the conclusion of the six month study period. Outcome assessment will focus on
phase lag and coherence of electroencephalogram (EEG) activity, which are
electrophysiological measures of cortical connectivity. Primary outcomes will also include
attention and memory functioning, which are measured prior to the start of treatment, one
week following the end of treatment and 6 months after treatment ends.
Interactive Metronome (IM) technology is a behavioral feedback operant conditioning
system.15 In biofeedback, physiological information is displayed to the patient but with IM
information about the patient's behavioral responses is provided to them. Below the
investigators provide a detailed description of the behavioral tasks and give some idea as
to the program's complexity and operation. IM technology takes advantage of each of the
above discussed factors related to neuroplastic processes and integrates them into a single
set of tasks that are designed to encourage integrated neuroplastic activity under
cognitively demanding circumstances. The computerized feedback is reliable, consistent,
timely, and directly correlated with motor output. The feedback is also presented in a rich
cognitive and sensory environment that combines instantaneous delivery of simultaneous
auditory and visual feedback following the motor response. This information aids the
preparation of the upcoming behavioral response. All of this feedback processing and
adjustment of behavioral responses must occur in just over a second (1.111 seconds) because
the default tempo for IM training is 54 beats per minute. This places a considerable
temporal demand upon the attentional, integration, decision making, inhibitory, and motor
output operators of the cortex, thereby increasing processing speed and efficiency over the
course of training.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT05503316 -
The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System
|
N/A | |
Completed |
NCT04356963 -
Adjunct VR Pain Management in Acute Brain Injury
|
N/A | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Terminated |
NCT03698747 -
Myelin Imaging in Concussed High School Football Players
|
||
Recruiting |
NCT05130658 -
Study to Improve Ambulation in Individuals With TBI Using Virtual Reality -Based Treadmill Training
|
N/A | |
Recruiting |
NCT04560946 -
Personalized, Augmented Cognitive Training (PACT) for Service Members and Veterans With a History of TBI
|
N/A | |
Completed |
NCT05160194 -
Gaining Real-Life Skills Over the Web
|
N/A | |
Recruiting |
NCT02059941 -
Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines
|
N/A | |
Recruiting |
NCT03940443 -
Differences in Mortality and Morbidity in Patients Suffering a Time-critical Condition Between GEMS and HEMS
|
||
Recruiting |
NCT03937947 -
Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
|
||
Completed |
NCT04465019 -
Exoskeleton Rehabilitation on TBI
|
||
Recruiting |
NCT04530955 -
Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)
|
N/A | |
Recruiting |
NCT03899532 -
Remote Ischemic Conditioning in Traumatic Brain Injury
|
N/A | |
Suspended |
NCT04244058 -
Changes in Glutamatergic Neurotransmission of Severe TBI Patients
|
Early Phase 1 | |
Completed |
NCT03307070 -
Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury
|
N/A | |
Recruiting |
NCT04274777 -
The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
|
||
Withdrawn |
NCT05062148 -
Fundamental and Applied Concussion Recovery Modality Research and Development: Applications for the Enhanced Recovery
|
N/A | |
Withdrawn |
NCT04199130 -
Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI
|
N/A | |
Withdrawn |
NCT03626727 -
Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia
|
Early Phase 1 |